CervoMed Inc (CRVO)
19.05
+0.04
(+0.21%)
USD |
NASDAQ |
Jun 17, 15:07
CervoMed Free Cash Flow: -7.392M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
March 31, 2024 | -7.392M |
December 31, 2023 | -7.450M |
September 30, 2023 | -5.604M |
June 30, 2023 | -1.450M |
March 31, 2023 | 0.6751M |
December 31, 2022 | -2.573M |
September 30, 2022 | -4.906M |
June 30, 2022 | -14.74M |
March 31, 2022 | -14.06M |
December 31, 2021 | -14.50M |
September 30, 2021 | -14.87M |
June 30, 2021 | -15.41M |
March 31, 2021 | -15.22M |
December 31, 2020 | -13.55M |
September 30, 2020 | -12.60M |
June 30, 2020 | -11.24M |
March 31, 2020 | -10.71M |
December 31, 2019 | -9.858M |
September 30, 2019 | -10.45M |
June 30, 2019 | -10.21M |
March 31, 2019 | -10.14M |
December 31, 2018 | -10.77M |
September 30, 2018 | -10.03M |
June 30, 2018 | -12.00M |
March 31, 2018 | -12.21M |
Date | Value |
---|---|
December 31, 2017 | -12.78M |
September 30, 2017 | -11.90M |
June 30, 2017 | -9.505M |
March 31, 2017 | -9.561M |
December 31, 2016 | -10.77M |
September 30, 2016 | -11.65M |
June 30, 2016 | -10.77M |
March 31, 2016 | -8.917M |
December 31, 2015 | -5.226M |
September 30, 2015 | -4.863M |
June 30, 2015 | -5.858M |
March 31, 2015 | -9.538M |
December 31, 2014 | -9.030M |
September 30, 2014 | -7.101M |
June 30, 2014 | -5.455M |
March 31, 2014 | -1.311M |
December 31, 2013 | -1.185M |
September 30, 2013 | -2.682M |
June 30, 2013 | -2.908M |
March 31, 2013 | -2.770M |
December 31, 2012 | -4.310M |
September 30, 2012 | -6.030M |
June 30, 2012 | -9.972M |
March 31, 2012 | -13.42M |
December 31, 2011 | -12.15M |
Free Cash Flow Range, Past 5 Years
-15.41M
Minimum
Jun 2021
0.6751M
Maximum
Mar 2023
-9.805M
Average
-10.58M
Median
Free Cash Flow Benchmarks
GlucoTrack Inc | -8.246M |
AIM ImmunoTech Inc | -23.04M |
Perspective Therapeutics Inc | -23.28M |
Protalix BioTherapeutics Inc | 4.369M |
Armata Pharmaceuticals Inc | -46.82M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | -1.424M |
Free Cash Flow Per Share (Quarterly) | -0.2307 |
Free Cash Flow Yield | -9.14% |